Profile picture

Doctor Lars Videbaek

Odense M (Denmark)
Follow
Logo ESC

Contributor content

Feasibility of HER2-directed therapy in an unselected clinical cohort of patients with HER2-positive breast cancer
Journal
Feasibility of HER2-directed therapy in an unselected clinical cohort of patients with HER2-positive breast cancer
1 August 2025
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources